Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure

Journal of the American College of Cardiology
Tseday E SirakThierry H Le Jemtel

Abstract

Patients with chronic heart failure (CHF) have a resting restrictive ventilatory defect. Any type of exercise requires patients with CHF to markedly increase their minute ventilation. Patients with chronic obstructive pulmonary disease (COPD) have airflow obstruction that leads to dynamic lung hyperinflation and reduced ventilatory response to exercise. Because exercise is associated with abnormally high minute ventilation in patients with CHF and with a limited minute ventilation increase in patients with COPD, functional capacity is severely impaired in patients with coexistent CHF and COPD. Optimal treatment of both conditions is a prerequisite to maximally improve functional capacity in patients with CHF and COPD. Unfortunately, beta-adrenergic blockade, the current cornerstone of CHF therapy, is frequently omitted in patients with CHF and COPD for fear of inducing bronchoconstriction. Furthermore, when prescribed, beta-adrenergic blockade is often attempted with a moderate dose of metoprolol tartrate, a beta-1-blocker that results in lesser clinical benefits than combined non-selective beta-blockade with carvedilol at the maximally recommended dose. Recent experience indicates that combined non-selective beta- and alpha-bl...Continue Reading

References

Oct 1, 1978·British Journal of Diseases of the Chest·C R McGavin, I P Williams
Feb 1, 1977·The Journal of Clinical Investigation·P D WagnerJ B West
Sep 1, 1992·American Heart Journal·J MyersV F Froelicher
Jan 1, 1991·Cardiovascular Drugs and Therapy·A E Tattersfield
Mar 1, 1991·The American Journal of Medicine·K O'MalleyE O'Brien
Jan 1, 1986·Journal of Cardiovascular Pharmacology·A E Tattersfield
Aug 1, 1983·British Journal of Pharmacology·U M Ney
Nov 22, 1984·The New England Journal of Medicine·M Kneussl, F Kummer
Aug 16, 1984·The New England Journal of Medicine·N J Gross, M S Skorodin
Jan 1, 1981·European Journal of Clinical Pharmacology·M E EllisS H Ellis
Jan 1, 1981·Respiration; International Review of Thoracic Diseases·W Van MieghemL Billiet
May 1, 1995·Journal of the American College of Cardiology·S L OlsenM R Bristow
Jan 1, 1993·Cardiology·P A van Zwieten
Oct 1, 1993·The American Review of Respiratory Disease·I M Weisman, R J Zeballos
Feb 1, 1993·The American Review of Respiratory Disease·A KoikeF Marumo
Aug 1, 1996·European Heart Journal·D C LindsayP A Poole-Wilson
Oct 23, 1997·Circulation·K WassermanP G Agostoni
Aug 14, 1998·General Pharmacology·E RouxR Marthan
Aug 26, 1998·The New England Journal of Medicine·S S GottliebR A Vogel
Mar 26, 1999·Journal of the American College of Cardiology·P S MacdonaldD J McCaffrey
Apr 10, 1999·Respiratory Medicine·I DimopoulouG E Tzelepis
Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·P D HughesM Green

❮ Previous
Next ❯

Citations

Jul 29, 2005·Zeitschrift für Kardiologie·U C HoppeUNKNOWN Vorstand der Deutschen Gesellschaft fur Kardiologie--Herz- und Kreislaufforschung e.V
May 25, 2007·Current Heart Failure Reports·S D Naik, Ronald S Freudenberger
Jan 1, 2010·Current Opinion in Pulmonary Medicine·Joana MascarenhasPaulo Bettencourt
Jun 21, 2008·American Journal of Respiratory and Critical Care Medicine·Yvette R B M van GestelDon Poldermans
May 6, 2008·Proceedings of the American Thoracic Society·Jeremy A FalkZab Mosenifar
May 6, 2008·Proceedings of the American Thoracic Society·Jeremy A FalkPhilip Diaz
Jun 12, 2009·International Journal of Chronic Obstructive Pulmonary Disease·Yvette R B M van GestelDon Poldermans
May 31, 2014·Clinics in Chest Medicine·Rachael A Evans, Michael D L Morgan
Feb 26, 2008·American Heart Journal·Joana MascarenhasPaulo Bettencourt
Nov 22, 2007·Journal of Internal Medicine·Y Blaauw, H J G M Crijns
Jul 14, 2007·European Journal of Heart Failure·Alejandro MacchiaGianni Tognoni
Jun 19, 2013·British Journal of Clinical Pharmacology·Daan W LothBruno H Stricker
Sep 15, 2007·Annales de cardiologie et d'angéiologie·R OllivierP Mabo
Feb 3, 2007·Expert Opinion on Pharmacotherapy·Marco MetraLivio Dei Cas
Sep 23, 2014·Drug Discovery Today·Mario MalerbaMario Pirisi
Oct 17, 2013·PloS One·Marian RyanCindy Parks Thomas
Jun 1, 2005·Lancet·John J V McMurray, Marc A Pfeffer
Apr 7, 2011·Circulation. Heart Failure·Rashmee U ShahPaul A Heidenreich
Sep 12, 2012·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·Andrew R L Medford
Nov 26, 2013·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·Alan KaplanAndrew R L Medford
Feb 27, 2015·American Journal of Therapeutics·Pramod Reddy, Lori Dupree
Jun 1, 2021·International Journal of Audiology·Deanna WungSophia E Kramer
Apr 11, 2020·Life Sciences·Xiao-Fang Li, Yi-Min Mao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.